1-8 of 8
t-cell activation
Close
Sort by
Journal Articles

Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma

Christie P. M. Verkleij, Marloes E. C. Broekmans, Mark van Duin, Kristine A. Frerichs, Rowan Kuiper, A. Vera de Jonge, Martin Kaiser, Gareth Morgan, Amy Axel, Rengasamy Boominathan, Jocelyn Sendecki, Amy Wong, Raluca I. Verona, Pieter Sonneveld, Sonja Zweegman, Homer C. Adams, III, Tuna Mutis, Niels W. C. J. van de Donk
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2196–2215.
https://doi.org/10.1182/bloodadvances.2020003805
Published: 2021
Includes: Supplemental data
Journal Articles

Teclistamab is an active T cell–redirecting bispecific antibody against B-cell maturation antigen for multiple myeloma

Kodandaram Pillarisetti, Gordon Powers, Leopoldo Luistro, Alexander Babich, Eric Baldwin, Yingzhe Li, Xiaochun Zhang, Mark Mendonça, Nate Majewski, Rupesh Nanjunda, Diana Chin, Kathryn Packman, Yusri Elsayed, Ricardo Attar, François Gaudet
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4538–4549.
https://doi.org/10.1182/bloodadvances.2020002393
Published: 2020
Includes: Supplemental data
Journal Articles

AMG 701 induces cytotoxicity of multiple myeloma cells and depletes plasma cells in cynomolgus monkeys

Rebecca L. Goldstein, Ana Goyos, Chi-Ming Li, Petra Deegen, Pamela Bogner, Alexander Sternjak, Oliver Thomas, Matthias Klinger, Joachim Wahl, Matthias Friedrich, Benno Rattel, Edwin Lamas, Xiaoshan Min, Athena Sudom, Mozhgan Farshbaf, Angela Coxon, Mercedesz Balazs, Tara Arvedson
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4180–4194.
https://doi.org/10.1182/bloodadvances.2020002565
Published: 2020
Includes: Supplemental data
Journal Articles

Cellular and molecular profiling of T-cell subsets at the onset of human acute GVHD

Eleonora Latis, David Michonneau, Claire Leloup, Hugo Varet, Régis Peffault de Latour, CRYOSTEM Consortium, Elisabetta Bianchi, Gérard Socié, Lars Rogge
Journal: Blood Advances
Blood Adv (2020) 4 (16): 3927–3942.
https://doi.org/10.1182/bloodadvances.2019001032
Published: 2020
Includes: Supplemental data
Journal Articles

A novel C2 domain binding CD33xCD3 bispecific antibody with potent T-cell redirection activity against acute myeloid leukemia

Priyanka Nair-Gupta, Michael Diem, Dara Reeves, Weirong Wang, Robert Schulingkamp, Katrin Sproesser, Bethany Mattson, Bradley Heidrich, Mark Mendonça, Jocelin Joseph, Jocelyn Sendecki, Brad Foulk, Gerald Chu, Damien Fink, Qun Jiao, Sheng-Jiun Wu, Kathryn Packman, Yusri Elsayed, Ricardo Attar, François Gaudet
Journal: Blood Advances
Blood Adv (2020) 4 (5): 906–919.
https://doi.org/10.1182/bloodadvances.2019001188
Published: 2020
Includes: Supplemental data
Journal Articles

Rational design of a trimeric APRIL-based CAR-binding domain enables efficient targeting of multiple myeloma

Andrea Schmidts, Maria Ormhøj, Bryan D. Choi, Allison O. Taylor, Amanda A. Bouffard, Irene Scarfò, Rebecca C. Larson, Matthew J. Frigault, Kathleen Gallagher, Ana P. Castano, Lauren S. Riley, Maria L. Cabral, Angela C. Boroughs, Rubí M.-H. Velasco Cárdenas, Wolfgang Schamel, Jing Zhou, Sean Mackay, Yu-Tzu Tai, Kenneth C. Anderson, Marcela V. Maus
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3248–3260.
https://doi.org/10.1182/bloodadvances.2019000703
Published: 2019
Includes: Supplemental data
Journal Articles

Soluble interleukin-2 receptor is a sensitive diagnostic test in adult HLH

Clinical Trials & Observations
Anna Hayden, Molly Lin, Sujin Park, Morris Pudek, Marion Schneider, Michael B. Jordan, Andre Mattman, Luke Y. C. Chen
Journal: Blood Advances
Blood Adv (2017) 1 (26): 2529–2534.
https://doi.org/10.1182/bloodadvances.2017012310
Published: 2017
Includes: Supplemental data
Journal Articles

Mature murine megakaryocytes present antigen-MHC class I molecules to T cells and transfer them to platelets

Anne Zufferey, Edwin R. Speck, Kellie R. Machlus, Rukhsana Aslam, Li Guo, Mark J. McVey, Michael Kim, Rick Kapur, Eric Boilard, Joseph E. Italiano, Jr, John W. Semple
Journal: Blood Advances
Blood Adv (2017) 1 (20): 1773–1785.
https://doi.org/10.1182/bloodadvances.2017007021
Published: 2017
Includes: Supplemental data